STING1 and cancer: Our analysis of mutation rates showed that the four STING pathway genes (cGAS, STING, TBK1 and IRF3) were usually not mutated in human cancers, with a complete absence of homozygous loss-of-function mutations in almost all cancer types (Supplementary Fig. S10A).